Home › Funds › Velan Capital Investment Management LP › EVMN

Velan Capital Investment Management LP position in EVMN

EVOMMUNE INC · Health Care

Velan Capital Investment Management LP reported holding 456,255 shares of EVMN (EVOMMUNE INC) in its Q3 2026 13F filing — a position valued at US$3.8M, representing 3.60% of its reported portfolio and ranking #11 among its reported holdings. Velan Capital Investment Management LP has disclosed EVMN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)456.25K sh
Reported value held$3.77M
Portfolio Weight3.60%
First reportedQ4 2025
Last changeAdd
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Velan Capital Investment Management LP's EVMN position evolved

Velan Capital Investment Management LP first disclosed a stake in EVMN in Q4 2025 at 506,754 shares (US$8.7M). The position peaked in Q1 2026 at 446,255 shares, worth US$10.3M. Across 4 filings, Velan Capital Investment Management LP increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 456,255 shares valued at US$3.8M — an increase of 5,000 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q4 2025 506.75K $8.68M New
Q1 2026 446.25K $10.26M Reduce
Q2 2026 451.25K $6.00M Add
Q3 2026 456.25K $3.77M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EVMN and 13F data

EVMN (EVOMMUNE INC) is a Health Care company. 93 other funds we track also report a position in EVMN — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$46.4M), EQT Fund Management S.a r.l. (US$43.7M), SymBiosis Capital Partners, LLC (US$29.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EVMN

All EVMN fund holders →

FAQ

How long has Velan Capital Investment Management LP held EVMN?

Velan Capital Investment Management LP has disclosed EVMN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Velan Capital Investment Management LP's current position in EVMN?

As of Q3 2026, Velan Capital Investment Management LP holds 456.25K shares of EVMN (EVOMMUNE INC), valued at $3.77M, representing 3.60% of its reported portfolio and ranking #11.

Has Velan Capital Investment Management LP been buying or selling EVMN?

In the latest 13F filing (Q3 2026), Velan Capital Investment Management LP increased its position in EVMN. The position peaked in Q1 2026 at 446.25K shares.

Which other funds hold EVMN?

Other major institutional holders of EVMN include RA CAPITAL MANAGEMENT, L.P., EQT Fund Management S.a r.l., SymBiosis Capital Partners, LLC, among 93 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.